Cytophage Technologies Ltd. (TSXV:CYTO)

Canada flag Canada · Delayed Price · Currency is CAD
0.1850
-0.0200 (-9.76%)
May 20, 2025, 4:00 PM EDT
-63.73%
Market Cap 9.98M
Revenue (ttm) n/a
Net Income (ttm) -7.86M
Shares Out 53.94M
EPS (ttm) -0.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 245,150
Average Volume 44,452
Open 0.2150
Previous Close 0.2050
Day's Range 0.1650 - 0.2150
52-Week Range 0.1250 - 0.5800
Beta 0.22
RSI 42.23
Earnings Date May 1, 2025

About Cytophage Technologies

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Winnipeg, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Steven Theriault
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol CYTO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.